Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity‐Matched Analysis
ABSTRACT Background Respiratory syncytial virus (RSV) is increasingly recognized as a trigger for adverse outcomes in older adults with heart failure (HF). Following FDA approval of RSV vaccines for adults ≥ 60 years in 2023, real‐world evidence in HF populations remains limited. Methods We conducted a multicenter retr...